Sarah Thurston
Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Models, Statistical | 6 | 1999 | 114 |
Why?
|
Methylmercury Compounds | 4 | 2007 | 25 |
Why?
|
Lung Neoplasms | 7 | 1999 | 159 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2007 | 46 |
Why?
|
Biometry | 2 | 2000 | 32 |
Why?
|
Occupational Diseases | 2 | 2000 | 51 |
Why?
|
Fishes | 2 | 2007 | 20 |
Why?
|
Seafood | 2 | 2007 | 8 |
Why?
|
Bayes Theorem | 1 | 2009 | 24 |
Why?
|
Smoking | 4 | 1999 | 153 |
Why?
|
Diet | 1 | 2007 | 87 |
Why?
|
Blood Pressure | 1 | 2007 | 205 |
Why?
|
Food Contamination | 3 | 2007 | 18 |
Why?
|
Industrial Oils | 1 | 2002 | 2 |
Why?
|
Regression Analysis | 5 | 1999 | 256 |
Why?
|
Child Development | 3 | 2007 | 49 |
Why?
|
Occupational Exposure | 1 | 2002 | 53 |
Why?
|
Menstruation Disturbances | 1 | 2000 | 9 |
Why?
|
Petroleum | 1 | 2000 | 3 |
Why?
|
Menstrual Cycle | 1 | 2000 | 13 |
Why?
|
Benzene | 1 | 2000 | 7 |
Why?
|
Models, Biological | 1 | 2005 | 410 |
Why?
|
Pregnancy | 5 | 2000 | 455 |
Why?
|
DNA Adducts | 3 | 1999 | 12 |
Why?
|
Motor Activity | 2 | 2007 | 104 |
Why?
|
Polymorphism, Genetic | 3 | 2001 | 94 |
Why?
|
Case-Control Studies | 3 | 2001 | 283 |
Why?
|
Seychelles | 3 | 2007 | 12 |
Why?
|
Child | 4 | 2007 | 749 |
Why?
|
Genes, p53 | 2 | 2001 | 43 |
Why?
|
Humans | 14 | 1999 | 1856 |
Why?
|
Monte Carlo Method | 1 | 2009 | 40 |
Why?
|
Markov Chains | 1 | 2009 | 25 |
Why?
|
Adult | 6 | 2000 | 1317 |
Why?
|
Child Behavior | 1 | 2009 | 41 |
Why?
|
Memory | 1 | 2009 | 61 |
Why?
|
Mercury Poisoning, Nervous System | 1 | 2009 | 8 |
Why?
|
Female | 9 | 1999 | 1643 |
Why?
|
Developmental Disabilities | 1 | 2009 | 54 |
Why?
|
Cognition | 1 | 2009 | 97 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 109 |
Why?
|
Male | 9 | 1999 | 1553 |
Why?
|
Environmental Monitoring | 2 | 2004 | 28 |
Why?
|
Water Pollutants, Chemical | 1 | 2007 | 9 |
Why?
|
Semen | 1 | 2007 | 15 |
Why?
|
Fertility | 1 | 2007 | 32 |
Why?
|
Longitudinal Studies | 1 | 2007 | 195 |
Why?
|
Logistic Models | 2 | 2001 | 251 |
Why?
|
Sex Factors | 1 | 2007 | 284 |
Why?
|
Double-Blind Method | 1 | 2007 | 274 |
Why?
|
Cohort Studies | 2 | 2002 | 332 |
Why?
|
Metallurgy | 1 | 2002 | 9 |
Why?
|
Cyclins | 1 | 2003 | 28 |
Why?
|
Prospective Studies | 1 | 2007 | 545 |
Why?
|
DNA Helicases | 1 | 2002 | 10 |
Why?
|
Biological Markers | 1 | 2004 | 262 |
Why?
|
Models, Theoretical | 1 | 2002 | 124 |
Why?
|
Animals | 2 | 2007 | 1031 |
Why?
|
Proportional Hazards Models | 1 | 2002 | 123 |
Why?
|
Aged | 5 | 1999 | 988 |
Why?
|
Oligomenorrhea | 1 | 2000 | 3 |
Why?
|
Confounding Factors (Epidemiology) | 1 | 2000 | 49 |
Why?
|
Glutathione Transferase | 1 | 2001 | 45 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2003 | 126 |
Why?
|
China | 1 | 2000 | 34 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 216 |
Why?
|
Binomial Distribution | 1 | 2000 | 2 |
Why?
|
Survival Analysis | 1 | 2002 | 205 |
Why?
|
Time Factors | 3 | 1999 | 896 |
Why?
|
Stress, Physiological | 1 | 2000 | 76 |
Why?
|
Middle Aged | 5 | 1999 | 1161 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2001 | 111 |
Why?
|
Brain Neoplasms | 1 | 2002 | 116 |
Why?
|
DNA, Neoplasm | 1 | 1999 | 75 |
Why?
|
Smoking Cessation | 1 | 2000 | 46 |
Why?
|
Proteins | 1 | 2002 | 192 |
Why?
|
Cross-Sectional Studies | 1 | 2000 | 253 |
Why?
|
DNA Damage | 1 | 1999 | 66 |
Why?
|
Adolescent | 1 | 2007 | 891 |
Why?
|
Adenocarcinoma | 1 | 2001 | 167 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 204 |
Why?
|
Prostatic Neoplasms | 1 | 2002 | 120 |
Why?
|
Algorithms | 1 | 2000 | 226 |
Why?
|
Transcription Factors | 1 | 2002 | 201 |
Why?
|
United States | 1 | 2002 | 604 |
Why?
|
Retrospective Studies | 1 | 2000 | 653 |
Why?
|
Codon | 2 | 2001 | 41 |
Why?
|
Arginine | 2 | 2001 | 57 |
Why?
|
Alleles | 2 | 2001 | 108 |
Why?
|
Genotype | 2 | 2001 | 175 |
Why?
|
Epidemiologic Studies | 1 | 2009 | 19 |
Why?
|
Endpoint Determination | 1 | 2009 | 27 |
Why?
|
Intelligence Tests | 1 | 2007 | 22 |
Why?
|
Sperm Count | 1 | 2007 | 10 |
Why?
|
Cluster Analysis | 1 | 2007 | 66 |
Why?
|
Intelligence | 1 | 2007 | 43 |
Why?
|
Social Environment | 1 | 2007 | 58 |
Why?
|
Data Collection | 1 | 2007 | 137 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 144 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 113 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 431 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 32 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 31 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 74 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2002 | 2 |
Why?
|
Research Design | 1 | 2004 | 169 |
Why?
|
Follow-Up Studies | 1 | 2007 | 553 |
Why?
|
Proline | 1 | 2001 | 30 |
Why?
|
Leukocytes | 1 | 2003 | 94 |
Why?
|
Infant | 1 | 2007 | 464 |
Why?
|
Risk | 1 | 2002 | 203 |
Why?
|
Child, Preschool | 1 | 2007 | 554 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 279 |
Why?
|
DNA Repair | 1 | 2002 | 47 |
Why?
|
Risk Assessment | 1 | 2004 | 324 |
Why?
|
Poisson Distribution | 1 | 1999 | 18 |
Why?
|
Genetic Predisposition to Disease | 1 | 2001 | 131 |
Why?
|
Autoradiography | 1 | 1999 | 73 |
Why?
|
Age Factors | 1 | 1999 | 480 |
Why?
|
RNA, Messenger | 1 | 2003 | 394 |
Why?
|
